Willow vs He & She MD: oral GLP-1, tracking, and pricing compared
Quick verdict: Willow positions an oral GLP-1 program around progress tracking and clinician follow-up, while He & She MD pairs lower intro pricing with a coaching app and multiple medication formats.
Explore Willow’s program and tracking tools
Willow vs He & She MD: what differs most
The primary differences between Willow and He & She MD center on medication format and pricing structure, bundled coaching and messaging, and the emphasis on follow-up and tracking. Below I compare these points directly using only the supplied facts.
1. Medication format and program focus
Willow: Telehealth-first oral GLP-1 program with a structured weight management journey and wellness tracking. Treatment is available only when a licensed clinician determines it is medically appropriate. Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
He & She MD: Offers semaglutide injection, oral semaglutide, or tirzepatide injection. Medications require consultation and prescription by clinician through He and She MD platform. Medications included in the GLP-1 Program are produced in USP-compliant, state-regulated pharmacies but not reviewed by the FDA for safety, efficacy, or quality.
See Willow’s oral GLP-1 workflow
2. Pricing and promotional structure
Willow: Starting price listed as 299. Price details beyond that starting entry were not captured on the readable landing page evidence.
He & She MD: Semaglutide injections start at $139/month and oral semaglutide and tirzepatide injections at $199/month as six-month introductory rates. The six-month intro rates renew higher; examples captured show renewal pricing equivalent to $199 to $289 per month depending on plan after the first six months. Promo pricing applies only to specified medications and terms.
Check He & She MD introductory pricing
3. Coaching, clinician access, and tracking
Willow: Emphasizes licensed telehealth team, progress tracking tools, and follow-up consultations as part of a structured support model to convert GLP-1 efficacy into long-term outcomes. Features listed include a licensed telehealth team and progress tracking tools.
He & She MD: Bundles a coaching app with 1:1 clinician messaging, GLP-1-specific coaching and built-in progress tracking at no extra cost. He & She MD positions clinician messaging and coaching as included in every plan, with free expedited shipping and no membership fee per the captured evidence.
4. Best fit and trade offs
Willow: Best for users who want structured digital follow-up and behavioral scaffolding alongside oral GLP-1. The program frames itself as a structured journey rather than a standalone medication subscription. Cons captured include higher monthly entry pricing for some plans and unreadable captured landing-page evidence.
He & She MD: Best for patients who want coaching and clinician access built into the plan and who may prefer lower six-month intro pricing. Cons captured include that headline prices are six-month intro rates that renew 30 to 45 percent higher and that compounded GLP-1s are not reviewed by the FDA for safety, efficacy or quality.
Comparison table: direct side-by-side
| Criteria | Willow | He & She MD |
|---|---|---|
| Primary offering | Oral GLP-1 with progress tracking and follow-up | Semaglutide injection, oral semaglutide, or tirzepatide injection plus app |
| Starting price | 299 | Semaglutide from $139/mo (intro) |
| Coaching and clinician access | Licensed telehealth team and follow-up consultations | 1:1 clinician messaging, GLP-1 coaching and tracking included |
| Pricing structure | Listed starting price; detailed page evidence not captured | Six-month introductory rates that renew higher |
| Shipping and fees | Not verified on the captured page | Free expedited shipping; no membership fee |
| Regulatory note | Compounded medications when offered are not FDA-approved; medication-specific approval status must be confirmed | Compounded medications not reviewed by FDA; produced in USP-compliant pharmacies per captured evidence |
What to expect from enrollment and support
Willow describes a simple digital workflow with licensed clinicians, progress tracking tools, and follow-up consultations to support a structured weight management journey. He & She MD emphasizes a fast intake, an app with 1:1 clinician messaging, and bundled coaching and tracking, noting that eligibility and prescriptions are subject to clinician review.
Explore He & She MD plans and app features
Conclusion and final guidance
Both Willow and He & She MD pair GLP-1 medication access with clinician oversight and tracking. Willow centers a telehealth-first oral GLP-1 program with structured follow-up and progress tools and lists a starting price of 299. He & She MD offers lower six-month introductory prices for semaglutide injections from $139/month and bundles 1:1 clinician messaging, coaching and tracking in its app but warns that intro rates renew higher after six months.
Choose Willow if you want an oral GLP-1 program explicitly framed as a structured weight management journey with progress tracking and follow-up consultations and are focused on that model.
Choose He & She MD if you prioritize lower introductory pricing, multiple medication formats, and an included coaching app with 1:1 clinician messaging and progress tracking.
Willow vs He & She MD: choose based on format, bundled coaching, and whether intro pricing or a structured follow-up model matters most to you.